PSA screening for prostate cancer

Detalhes bibliográficos
Autor(a) principal: Sadi, Marcus V. [UNIFESP]
Data de Publicação: 2017
Tipo de documento: Artigo (review)
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/00130000122hj
Texto Completo: http://dx.doi.org/10.1590/1806-9282.63.08.722
http://repositorio.unifesp.br/handle/11600/51414
Resumo: Screening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results of radical curative treatment for low grade tumors and the complications resulting from treatments that affect the patient's quality of life. Our review aimed to critically analyze the current recommendations for PSA testing, based on new data provided by the re-evaluation of the ongoing studies and the updated USPSTF recommendation statement, and to propose a more rational and selective use of PSA compared with baseline values obtained at an approximate age of 40 to 50 years.
id UFSP_cf3116f3f95ce06c2a72391a9f76a305
oai_identifier_str oai:repositorio.unifesp.br/:11600/51414
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling PSA screening for prostate cancerRastreamento do câncer de próstata com PSAPSAprostate cancerscreeningprostatePSAcâncer de próstatarastreamentopróstataScreening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results of radical curative treatment for low grade tumors and the complications resulting from treatments that affect the patient's quality of life. Our review aimed to critically analyze the current recommendations for PSA testing, based on new data provided by the re-evaluation of the ongoing studies and the updated USPSTF recommendation statement, and to propose a more rational and selective use of PSA compared with baseline values obtained at an approximate age of 40 to 50 years.O rastreamento do câncer de próstata com antígeno prostático específico (PSA) é uma questão altamente controversa. Parte da polêmica se deve à confusão entre rastreamento populacional e diagnóstico precoce, e outra parte está ligada a problemas relacionados à qualidade dos estudos de rastreamento recentes, a resultados do tratamento curativo radical para tumores de baixo grau ou em estágio precoce, e a complicações advindas de tratamentos que afetam a qualidade de vida do paciente. Nossa revisão teve como objetivo analisar criticamente as recomendações atuais para o teste de PSA, com base em dados obtidos da reavaliação de estudos em andamento e na recomendação atualizada do USPSTF, e propor o uso mais racional e seletivo do PSA comparado a níveis iniciais obtidos em uma idade aproximada de 40 a 50 anos.Univ Fed São Paulo EPM Unifesp, Escola Paulista Med, Urol, São Paulo, SP, BrazilEPM Unifesp, Urol Oncol Sect, São Paulo, SP, BrazilAcad Med São Paulo, São Paulo, SP, BrazilUniv Fed São Paulo EPM Unifesp, Escola Paulista Med, Urol, São Paulo, SP, BrazilEPM Unifesp, Urol Oncol Sect, São Paulo, SP, BrazilWeb of ScienceAssoc Medica Brasileira2019-08-19T11:49:50Z2019-08-19T11:49:50Z2017info:eu-repo/semantics/reviewinfo:eu-repo/semantics/publishedVersion722-725application/pdfhttp://dx.doi.org/10.1590/1806-9282.63.08.722Revista Da Associacao Medica Brasileira. Sao Paulo, v. 63, n. 8, p. 722-725, 2017.10.1590/1806-9282.63.08.722WOS000412280300011.pdf0104-4230S0104-42302017000800722http://repositorio.unifesp.br/handle/11600/51414WOS:000412280300011ark:/48912/00130000122hjenginfo:eu-repo/semantics/openAccessSadi, Marcus V. [UNIFESP]reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-10T23:39:08Zoai:repositorio.unifesp.br/:11600/51414Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:50:41.734195Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv PSA screening for prostate cancer
Rastreamento do câncer de próstata com PSA
title PSA screening for prostate cancer
spellingShingle PSA screening for prostate cancer
Sadi, Marcus V. [UNIFESP]
PSA
prostate cancer
screening
prostate
PSA
câncer de próstata
rastreamento
próstata
title_short PSA screening for prostate cancer
title_full PSA screening for prostate cancer
title_fullStr PSA screening for prostate cancer
title_full_unstemmed PSA screening for prostate cancer
title_sort PSA screening for prostate cancer
author Sadi, Marcus V. [UNIFESP]
author_facet Sadi, Marcus V. [UNIFESP]
author_role author
dc.contributor.author.fl_str_mv Sadi, Marcus V. [UNIFESP]
dc.subject.por.fl_str_mv PSA
prostate cancer
screening
prostate
PSA
câncer de próstata
rastreamento
próstata
topic PSA
prostate cancer
screening
prostate
PSA
câncer de próstata
rastreamento
próstata
description Screening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results of radical curative treatment for low grade tumors and the complications resulting from treatments that affect the patient's quality of life. Our review aimed to critically analyze the current recommendations for PSA testing, based on new data provided by the re-evaluation of the ongoing studies and the updated USPSTF recommendation statement, and to propose a more rational and selective use of PSA compared with baseline values obtained at an approximate age of 40 to 50 years.
publishDate 2017
dc.date.none.fl_str_mv 2017
2019-08-19T11:49:50Z
2019-08-19T11:49:50Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/review
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format review
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/1806-9282.63.08.722
Revista Da Associacao Medica Brasileira. Sao Paulo, v. 63, n. 8, p. 722-725, 2017.
10.1590/1806-9282.63.08.722
WOS000412280300011.pdf
0104-4230
S0104-42302017000800722
http://repositorio.unifesp.br/handle/11600/51414
WOS:000412280300011
dc.identifier.dark.fl_str_mv ark:/48912/00130000122hj
url http://dx.doi.org/10.1590/1806-9282.63.08.722
http://repositorio.unifesp.br/handle/11600/51414
identifier_str_mv Revista Da Associacao Medica Brasileira. Sao Paulo, v. 63, n. 8, p. 722-725, 2017.
10.1590/1806-9282.63.08.722
WOS000412280300011.pdf
0104-4230
S0104-42302017000800722
WOS:000412280300011
ark:/48912/00130000122hj
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 722-725
application/pdf
dc.publisher.none.fl_str_mv Assoc Medica Brasileira
publisher.none.fl_str_mv Assoc Medica Brasileira
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1818602553910231040

Registros relacionados